Robert is CEO of spinout company Immetacyte Ltd and Honorary Professor of Medical Oncology at the University of Manchester / The Christie Hospital. After medical school at Trinity College Cambridge and University College London, he undertook a PhD in Antibody Engineering with Sir Gregory Winter at the MRC Laboratory of Molecular Biology in Cambridge. As Professor of Medical Oncology from 1998-2019, he developed a clinical and preclinical research program in immuno-oncology at the University of Manchester. He has been the coordinator of several major European Union consortia in adoptive cell therapy and has published widely in scientific and clinical journals.

Share Share It FB TW GP